CD8A and neoplasm: To evaluate the effector functions of CD8+ TILs in EMPD patients, we analyzed the cytotoxicity and the effector functions of CD8+ T cells using paired samples of PBMCs and tumor tissues of 10 EMPD patients, following the protocol described previously [6,7,15].